GRANT AVENUE CAPITAL LLC
GRANT AVENUE CAPITAL LLC is a Series C+ and buyout fund in the US writing $25M–$350M checks into Healthcare and healthcare-tech.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, healthcare-tech
- Check size
- $25M–$350M
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2019
- Assets under management
- $716M
- Website
- grantave.com
Thesis
Grant Avenue Capital is a private equity firm founded in 2019 and headquartered in New York, NY. The firm exclusively targets the US healthcare sector, focusing on middle-market companies. Their investment strategy includes control buyouts, buy-and-builds, corporate carve-outs, joint-control partnerships, and special situations. They seek fragmented, recession-resilient healthcare categories with proven customer value and no new product launch or FDA approval risk. Core investment themes are cost containment, custom solutions, consumerism in healthcare, and compliance-focused technology. The firm utilizes a 'Grant Advantage' program encompassing Equity Alpha Drivers, a Value Creation Playbook, and Human Capital & Talent, supported by a deep healthcare and executive network. As of May 5, 2026, they managed $716 million in client assets. They target platform investments with an EBITDA of $5-25 million and an Enterprise Value of $25-350 million. The firm also supports community initiatives through the Grant Avenue Foundation.
Common questions
Does GRANT AVENUE CAPITAL LLC invest at the Series C+ stage?
Yes. GRANT AVENUE CAPITAL LLC lists Series C+ and buyout among the stages it invests in.
What check size does GRANT AVENUE CAPITAL LLC write?
GRANT AVENUE CAPITAL LLC writes $25M–$350M checks.
Where does GRANT AVENUE CAPITAL LLC invest?
GRANT AVENUE CAPITAL LLC invests in the US.